AEON Biopharma, Inc.
AEON · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $1 | $1 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | -$3 | -$3 |
| Operating Expenses | $2 | $4 | $0 | $2 |
| Operating Income | -$2 | -$4 | -$0 | -$2 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$2 | $10 | $4 |
| Pre-Tax Income | -$5 | -$7 | $9 | $2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$7 | $9 | $2 |
| % Margin | – | – | – | – |
| EPS | -0.39 | -0.6 | 2.28 | 3.76 |
| % Growth | 35% | -126.3% | -39.4% | – |
| EPS Diluted | -0.39 | -0.6 | 2.28 | 3.47 |
| Weighted Avg Shares Out | 12 | 11 | 4 | 1 |
| Weighted Avg Shares Out Dil | 12 | 11 | 4 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$4 | -$4 | -$6 |
| % Margin | – | – | – | – |